Latest National Institute of Diabetes and Digestive and Kidney Diseases Stories
Medication used to treat patients with type II diabetes activates sensors on brain cells that increase hunger, causing people taking this drug to gain more body fat, according to researchers at
Approach could help focus efforts on those who stand to gain most from drugs & lifestyle change, and could be used for other diseases ANN ARBOR, Mich., Feb.
Rosellini Scientific has been awarded an NIH Small Business Innovation Research (SBIR) grant to develop a new treatment for Overactive Bladder (OAB).
Funding provided to support human clinical evaluation of next generation diabetes monitoring system SAN DIEGO, Nov.
TEL AVIV, Israel, Nov. 5, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
PASADENA, Calif., Oct.
- an ornament or knob in the shape of a flower